HACEK infectious endocarditis: case report
PDF (Português (Brasil))

Keywords

Heart infection
Endocarditis
Cardiology
Clinical Medicine

How to Cite

Domingues, A. L. G., & Rostirola, L. S. (2023). HACEK infectious endocarditis: case report. Journal of Medical Residency Review, 2(1), e038. https://doi.org/10.37497/JMRReview.v2i1.38

Abstract

Background: Infectious endocarditis (IE) is an infection of the cardiac endothelium that can usually be caused by bacteria and fungi. The superficial growth of these microorganisms (MOs) can cause embolism in various organs, such as kidneys, lungs, skin, brain and central nervous system, leading to death if not treated properly. IE caused by HACEK bacteria (Haemophilus spp., Aggregatibacter actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens and Kingella kingae) mainly affects patients with previous heart disease or artificial valves, and is characterized by an insidious course, with an average delay in diagnosis of one month (when caused by Haemophilus spp.) to 3 months (when caused by Aggregatibacter or Cardiobacterium spp.). Aim: To report a case of IE caused by MOs from the HACEK group.

Method: This is the report of a patient treated at the Hospital Universitário São Francisco na Providência de Deus – HUSF, located in the city of Bragança Paulista – SP, Brazil. Case Report: This report describes the case of a 50-year-old male patient with a history of persistent fever, sweating, chills, fatigue and weight loss. After clinical evaluation, the patient was diagnosed with IE, based on clinical, laboratory and imaging findings, including microcytic anemia, leukocytosis with left shift, elevated PCR and VHS, presence of diastolic murmur, in addition to evidence of cardiac valve involvement in the transthoracic echocardiogram. Blood cultures identified the bacteria A. aphrophilus as the cause of IE, and treatment with ceftriaxone was initiated. Due to significant valve dysfunction, the patient underwent cardiac surgery with replacement of the tricuspid valve with a mitral prosthesis, followed by outpatient/cardiological monitoring and dental evaluation.

Conclusion: HACEK MOs can cause IE in patients of different age groups, including children, and their ability to affect both native and prosthetic valves highlights the importance of a broad clinical approach and a high index of suspicion for accurate diagnosis. Furthermore, maintaining oral health is an important factor in preventing these infections, and the use of imaging tests, such as CT scans and echocardiograms, and blood cultures play a fundamental role in identification and appropriate treatment of patients with IE caused by HACEK. Therefore, understanding these aspects is essential to improve the diagnosis and clinical management of these infections, which can lead to substantial morbidity and mortality if not detected and treated in a timely manner.

https://doi.org/10.37497/JMRReview.v2i1.38
PDF (Português (Brasil))

References

BADDOUR, L. M. et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation, v. 132, n. 15, p. 1435–1486, 13 out. 2015.

BARON, E. J.; SCOTT, J. D.; TOMPKINS, L. S. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, v. 41, n. 11, p. 1677–1680, 1 dez. 2005.

BERGE, A. et al. Epidemiology, bacteriology, and clinical characteristics of HACEK bacteremia and endocarditis: a population-based retrospective study. European Journal of Clinical Microbiology & Infectious Diseases, v. 40, n. 3, p. 525–534, 2021.

BROUQUI, P.; RAOULT, D. Endocarditis due to rare and fastidious bacteria. Clinical Microbiology Reviews, v. 14, n. 1, p. 177–207, jan. 2001.

CAHILL, T. J. et al. Challenges in Infective Endocarditis. Journal of the American College of Cardiology, v. 69, n. 3, p. 325–344, 24 jan. 2017.

CHAMBERS, S. T. et al. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PloS One, v. 8, n. 5, p. e63181, 2013.

CORREA DE SA, D. D. et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clinic Proceedings, v. 85, n. 5, p. 422–426, maio 2010.

DAS, M. et al. Infective endocarditis caused by HACEK microorganisms. Annual Review of Medicine, v. 48, p. 25–33, 1997.

DURACK, D. T.; LUKES, A. S.; BRIGHT, D. K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. The American Journal of Medicine, v. 96, n. 3, p. 200–209, mar. 1994.

FORTINI, M. B.; MCNEIL, J. C. HACEK Infective Endocarditis at a Tertiary Children’s Hospital. The Journal of Pediatrics, v. 235, p. 284–287, ago. 2021.

HABIB, G. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal, v. 36, n. 44, p. 3075–3128, 21 nov. 2015.

KHALEDI, M. et al. Infective endocarditis by HACEK: a review. Journal of Cardiothoracic Surgery, v. 17, p. 185, 19 ago. 2022.

KUOHN, L. R. et al. Bacterial endocarditis with AACEK (HACEK) organisms. Echocardiography (Mount Kisco, N.Y.), v. 39, n. 10, p. 1348–1358, out. 2022.

LEPIDI, H. et al. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. The Journal of Infectious Diseases, v. 193, n. 12, p. 1711–1717, 15 jun. 2006.

MORRIS, A. J. et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, v. 36, n. 6, p. 697–704, 15 mar. 2003.

MUÑOZ, P. et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine, v. 94, n. 43, p. e1816, out. 2015.

MURDOCH, D. R. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine, v. 169, n. 5, p. 463–473, 9 mar. 2009.

NISHIMURA, R. A. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, v. 63, n. 22, p. 2438–2488, 10 jun. 2014.

PATUREL, L. et al. Actinobacillus actinomycetemcomitans endocarditis. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, v. 10, n. 2, p. 98–118, fev. 2004.

RAJANI, R.; KLEIN, J. L. Infective endocarditis: A contemporary update. Clinical Medicine, v. 20, n. 1, p. 31–35, jan. 2020.

REVEST, M. et al. HACEK endocarditis: state-of-the-art. Expert Review of Anti-Infective Therapy, v. 14, n. 5, p. 523–530, 2016.

SELTON-SUTY, C. et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, v. 54, n. 9, p. 1230–1239, maio 2012.

SHARARA, S. L. et al. HACEK endocarditis: a review. Expert Review of Anti-Infective Therapy, v. 14, n. 6, p. 539–545, jun. 2016.

TOYODA, N. et al. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA, v. 317, n. 16, p. 1652–1660, 25 abr. 2017.

VON REYN, C. F. et al. Infective endocarditis: an analysis based on strict case definitions. Annals of Internal Medicine, v. 94, n. 4 pt 1, p. 505–518, abr. 1981.

WASSEF, N. et al. HACEK-induced endocarditis. BMJ case reports, v. 2013, p. bcr2012007359, 15 maio 2013.

WERNER, M. et al. A clinical study of culture-negative endocarditis. Medicine, v. 82, n. 4, p. 263–273, jul. 2003.

WERNER, M. et al. A 10-year survey of blood culture negative endocarditis in Sweden: aminoglycoside therapy is important for survival. Scandinavian Journal of Infectious Diseases, v. 40, n. 4, p. 279–285, 2008.

YALLOWITZ, A. W.; DECKER, L. C. Infectious Endocarditis. Em: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.